Literature DB >> 24920813

Genomic flexibility of human endogenous retrovirus type K.

Derek Dube1, Rafael Contreras-Galindo1, Shirley He1, Steven R King1, Marta J Gonzalez-Hernandez2, Scott D Gitlin3, Mark H Kaplan1, David M Markovitz4.   

Abstract

UNLABELLED: Human endogenous retrovirus type K (HERV-K) proviruses are scattered throughout the human genome, but as no infectious HERV-K virus has been detected to date, the mechanism by which these viruses replicated and populated the genome remains unresolved. Here, we provide evidence that, in addition to the RNA genomes that canonical retroviruses package, modern HERV-K viruses can contain reverse-transcribed DNA (RT-DNA) genomes. Indeed, reverse transcription of genomic HERV-K RNA into the DNA form is able to occur in three distinct times and locations: (i) in the virus-producing cell prior to viral release, yielding a DNA-containing extracellular virus particle similar to the spumaviruses; (ii) within the extracellular virus particle itself, transitioning from an RNA-containing particle to a DNA-containing particle; and (iii) after entry of the RNA-containing virus into the target cell, similar to canonical retroviruses, such as murine leukemia virus and HIV. Moreover, using a resuscitated HERV-K virus construct, we show that both viruses with RNA genomes and viruses with DNA genomes are capable of infecting target cells. This high level of genomic flexibility historically could have permitted these viruses to replicate in various host cell environments, potentially assisting in their many integration events and resulting in their high prevalence in the human genome. Moreover, the ability of modern HERV-K viruses to proceed through reverse transcription and package RT-DNA genomes suggests a higher level of replication competency than was previously understood, and it may be relevant in HERV-K-associated human diseases. IMPORTANCE: Retroviral elements comprise at least 8% of the human genome. Of all the endogenous retroviruses, HERV-K viruses are the most intact and biologically active. While a modern infectious HERV-K has yet to be found, HERV-K activation has been associated with cancers, autoimmune diseases, and HIV-1 infection. Thus, determining how this virus family became such a prevalent member of our genome and what it is capable of in its current form are of the utmost importance. Here, we provide evidence that HERV-K viruses currently found in the human genome are able to proceed through reverse transcription and historically utilized a life cycle with a surprising degree of genomic flexibility in which both RNA- and DNA-containing viruses were capable of mediating infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24920813      PMCID: PMC4136327          DOI: 10.1128/JVI.01147-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Biphasic DNA synthesis in spumaviruses.

Authors:  Olivier Delelis; Ali Saïb; Pierre Sonigo
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 2.  The replication strategy of foamy viruses.

Authors:  A Rethwilm
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

3.  Human foamy virus reverse transcription that occurs late in the viral replication cycle.

Authors:  A Moebes; J Enssle; P D Bieniasz; M Heinkelein; D Lindemann; M Bock; M O McClure; A Rethwilm
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  In vitro synthesis of infectious DNA of murine leukaemia virus.

Authors:  E Rothenberg; D Smotkin; D Baltimore; R A Weinberg
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

5.  HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro.

Authors:  Rafael Contreras-Galindo; Pablo López; Rosa Vélez; Yasuhiro Yamamura
Journal:  AIDS Res Hum Retroviruses       Date:  2007-01       Impact factor: 2.205

6.  Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations.

Authors:  Catriona Macfarlane; Peter Simmonds
Journal:  J Mol Evol       Date:  2004-11       Impact factor: 2.395

Review 7.  Retroelements and the human genome: new perspectives on an old relation.

Authors:  Norbert Bannert; Reinhard Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

8.  Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals.

Authors:  H Zhang; O Bagasra; M Niikura; B J Poiesz; R J Pomerantz
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Identification of human endogenous retroviruses with complex mRNA expression and particle formation.

Authors:  R Löwer; K Boller; B Hasenmaier; C Korbmacher; N Müller-Lantzsch; J Löwer; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

Review 10.  Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?

Authors:  Joseph M Antony; Andre M Deslauriers; Rakesh K Bhat; Kristofer K Ellestad; Christopher Power
Journal:  Biochim Biophys Acta       Date:  2010-08-06
View more
  13 in total

Review 1.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

2.  Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Derek Dube; Marta J Gonzalez-Hernandez; Susana Chan; Fan Meng; Manhong Dai; Gilbert S Omenn; Scott D Gitlin; David M Markovitz
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 3.  Endogenous retrovirus-K and nervous system diseases.

Authors:  Mamneet Manghera; Jennifer Ferguson; Renée Douville
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

4.  Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.

Authors:  Rafael Contreras-Galindo; Derek Dube; Koh Fujinaga; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 5.  Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis.

Authors:  Wenxue Li; Darshan Pandya; Nicholas Pasternack; Marta Garcia-Montojo; Lisa Henderson; Christine A Kozak; Avindra Nath
Journal:  Neurotherapeutics       Date:  2022-04-12       Impact factor: 6.088

6.  Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy.

Authors:  M Garcia-Montojo; S Fathi; G Norato; B R Smith; D B Rowe; M C Kiernan; S Vucic; S Mathers; R P A van Eijk; U Santamaria; M-L Rogers; A Malaspina; V Lombardi; P R Mehta; H-J Westeneng; L H van den Berg; A Al-Chalabi; J Gold; A Nath
Journal:  J Neurol Sci       Date:  2021-02-23       Impact factor: 3.181

7.  Expansion of a novel endogenous retrovirus throughout the pericentromeres of modern humans.

Authors:  Joseph Zahn; Mark H Kaplan; Sabrina Fischer; Manhong Dai; Fan Meng; Anjan Kumar Saha; Patrick Cervantes; Susana M Chan; Derek Dube; Gilbert S Omenn; David M Markovitz; Rafael Contreras-Galindo
Journal:  Genome Biol       Date:  2015-04-12       Impact factor: 13.583

8.  ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease.

Authors:  Mamneet Manghera; Jennifer Ferguson; Renée Douville
Journal:  Viruses       Date:  2015-01-20       Impact factor: 5.048

9.  A contaminant-free assessment of Endogenous Retroviral RNA in human plasma.

Authors:  Timokratis Karamitros; Dimitrios Paraskevis; Angelos Hatzakis; Mina Psichogiou; Ioannis Elefsiniotis; Tara Hurst; Anna-Maria Geretti; Apostolos Beloukas; John Frater; Paul Klenerman; Aris Katzourakis; Gkikas Magiorkinis
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

10.  Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication.

Authors:  Marian P Laderoute; Louise J Larocque; Antonio Giulivi; Francisco Diaz-Mitoma
Journal:  Open AIDS J       Date:  2015-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.